Thus, even in middle-aged and older adults with preserved kidney function, subclinical left ventricular hypertrophy may enhance cardiomyocyte-derived FGF23 production, potentially causing mild elevations in circulating FGF23 levels. Here, FGF23 is linked to left ventricular hypertrophy.